KOVERA LABS · CLIENT RECORD·SNAPSHOT 2026-08-02
Coffee and Peppers: 54 Kovera certificates.
The lab's record shows 54 certificates printed for Coffee and Peppers, analysed between 26 Feb 2026 and 4 May 2026, covering 27 products. Median HPLC purity is 99.95%. Kovera graded 54 as a pass and 0 as a fail.
54
certificates
99.95%
median purity
27
products
0
lab verdict: fail
0
failure rules met
What the record shows
RETRIEVED 2 AUGUST 2026None of the 54 certificates meets our failure rules: no lab fail, no unconfirmed identity, no purity under 95% and no content under 90% of the label. 29 measured more than 110% of the label, which Kovera does not grade as a fail.
A certificate covers the sample the client sent, and the client decides which results go public. The figures are as published on 2 August 2026; check the lab's verify page for the current version before you rely on one.
Products tested
27 AS PRINTEDGLP-3 RT · 10Retatrutide · 6BPC-157 · 3Selank · 3Tesamorelin · 35-Amino-1MQ · 2BPC-157/TB-500 · 2CJC-1295 (No DAC)/Ipamorelin · 2GLP-2 TZ · 2KPV · 2MOTS-c · 2PT-141 · 2AOD-9604 · 1Cagrilintide · 1GHK-Cu · 1Glow · 1Glutathione · 1IGF-LR3 · 1Klow · 1Melanotan-2 · 1MOTS-C · 1N-Acetyl Selank Amidate · 1N-Acetyl Semax Amidate · 1Semax · 1TB-500 (43aa) · 1TB-500 (Thymosin B4) · 1Tirzepatide · 1
Every certificate
NEWEST FIRST · 54 ROWS| Report | Product | Lot | Purity | % of label | Analysed | Result | Check |
|---|---|---|---|---|---|---|---|
| KVR-2026-716EF1 | BPC-157 | CPBPC26041404 | 99.866% | 92.8%9.28 of 10 mg | 4 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-F9C09B | GLP-3 RT | CPR3026040906 | 99.851% | 97.7%29.31 of 30 mg | 19 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-BC95E4 | N-Acetyl Semax Amidate | CPSMAX1026040901 | 99.942% | 112.1%11.21 of 10 mg | 19 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-9A13C2 | GLP-3 RT | CPR3026040905 | 99.819% | 103.5%31.06 of 30 mg | 19 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-0B6A93 | GLP-3 RT | CPR3026040904 | 99.831% | 109.0%32.71 of 30 mg | 19 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-F2EB47 | N-Acetyl Selank Amidate | CPSELANK1026040905 | 99.982% | 116.6%11.66 of 10 mg | 12 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-E42FCD | GLP-2 TZ | CPT6026040202 | 99.876% | 105.5%63.28 of 60 mg | 12 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-B4433F | MOTS-c | CPMOTS1026040206 | 99.862% | 117.2%11.72 of 10 mg | 12 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-AEB7B8 | PT-141 | CPPT1026040201 | 99.907% | 110.8%11.08 of 10 mg | 12 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-6578D9 | PT-141 | CPPT1026040902 | 99.919% | 117.2%11.72 of 10 mg | 12 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-5EDCD8 | Glutathione | CPGLUTA75026040201 | 99.951% | 98.4%738.26 of 750 mg | 12 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-59AF9A | BPC-157 | CPBPC26040103 | 99.861% | 112.6%11.26 of 10 mg | 12 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-2D09E3 | GLP-3 RT | CPR1026040907 | 99.823% | 110.8%11.08 of 10 mg | 12 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-0F8EC3 | GLP-3 RT | CPR1026040908 | 99.849% | 118.2%11.82 of 10 mg | 12 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-F8663C | CJC-1295 (No DAC)/Ipamorelin | CPCJCIPA1026040103 | 99.698% | 109.0%10.9 of 10 mg | 7 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-B69C2E | GLP-2 TZ | CPT1026040102 | 99.972% | 112.7%11.27 of 10 mg | 7 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-B185D9 | Tesamorelin | CPTESA1026040103 | 99.957% | 115.2%11.52 of 10 mg | 7 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-98B2A9 | GLP-3 RT | CPR5026040103 | 99.977% | 105.8%52.92 of 50 mg | 7 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-58C421 | GLP-3 RT | CPR3026040103 | 99.926% | 103.8%31.13 of 30 mg | 7 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-06DF99 | GLP-3 RT | CPR1026040106 | 99.988% | 106.3%10.63 of 10 mg | 7 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-45A732 | Selank | CPSELANK1026033104 | 99.949% | 106.3%10.63 of 10 mg | 6 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-F3CD23 | Semax | CPSMAX526033001 | 99.947% | 108.4%5.42 of 5 mg | 4 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-93ADCF | Melanotan-2 | CPMT1026033001 | 99.964% | 105.4%10.54 of 10 mg | 4 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-840D92 | KPV | CPKPV1026033002 | 99.977% | 117.1%11.71 of 10 mg | 4 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-759B8F | Tirzepatide | CPT6026033001 | 99.968% | 106.6%63.98 of 60 mg | 4 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-2A3D60 | MOTS-c | CPMOTS1026033005 | 99.949% | 116.6%11.66 of 10 mg | 4 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-FEEC57 | Selank | CPSELANK1026032703 | 99.982% | 115.2%11.52 of 10 mg | 31 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-66145A | TB-500 (Thymosin B4) | CPTB1026032703 | 99.949% | 114.3%11.43 of 10 mg | 31 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-D1782D | BPC-157 | CPBPC26032502 | 99.977% | 107.8%10.78 of 10 mg | 30 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-29C1FE | GLP-3 RT | CPR1026032405 | 99.986% | 98.4%9.84 of 10 mg | 30 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-5F342A | GLP-3 RT | CPR1026032405 | 99.984% | 98.4%9.84 of 10 mg | 28 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-E14104 | BPC-157/TB-500 | CPBPCTB2026032401 | 99.781% | 110.8%22.17 of 20 mg | 24 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-CCBE17 | Tesamorelin | CPTESA1026032402 | 99.972% | 105.8%10.58 of 10 mg | 24 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-C958C2 | TB-500 (43aa) | CPTB1026032301 | 99.931% | 115.3%11.53 of 10 mg | 24 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-C3ACA3 | Retatrutide | CPR1026032304 | 99.949% | 112.1%11.21 of 10 mg | 24 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-AAF939 | Retatrutide | CPR3026032302 | 99.947% | 112.7%33.82 of 30 mg | 24 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-9F953F | Tesamorelin | CPTESA1026032001 | 99.926% | 106.8%10.68 of 10 mg | 24 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-2F0213 | BPC-157/TB-500 | CPBPCTB1026032503 | 99.859% | 114.3%11.43 of 10 mg | 24 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-FA0CA3 | Retatrutide | CPR5026031602 | 99.971% | 110.9%55.47 of 50 mg | 22 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-DE15B1 | Klow | CPKLOW26031801 | 99.841% | 109.3%87.47 of 80 mg | 22 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-C6D23A | CJC-1295 (No DAC)/Ipamorelin | CPCJCIPA1026031602 | 99.807% | 111.9%11.19 of 10 mg | 22 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-867E20 | AOD-9604 | CPAOD26031601 | 99.934% | 113.8%5.69 of 5 mg | 22 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-5C41DD | 5-Amino-1MQ | CP5AM26031602 | 99.979% | 105.7%10.57 of 10 mg | 22 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-2A4F3F | Retatrutide | CPR2026031702 | 99.956% | 108.2%21.63 of 20 mg | 22 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-C91747 | Glow | CPGLOW26031402 | 99.927% | 109.0%76.27 of 70 mg | 19 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-C61303 | KPV | CPKPV1026031401 | 99.973% | 116.1%11.61 of 10 mg | 19 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-4E8D8A | Retatrutide | CPR1026030102 | 99.971% | 115.9%11.59 of 10 mg | 10 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-561C0E | Retatrutide | CPR1026030703 | 99.949% | 120.8%12.08 of 10 mg | 9 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-4638B0 | Cagrilintide | CPCAGRI526030701 | 99.953% | 137.8%6.89 of 5 mg | 9 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-DDBF5B | Selank | CPSELANK1026030302 | 99.926% | 118.9%11.89 of 10 mg | 5 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-6F0B47 | IGF-LR3 | CPIGF126022501 | 99.942% | 107.0%1.07 of 1 mg | 5 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-007B56 | MOTS-C | CPMOTS1026030104 | 99.978% | 115.8%11.58 of 10 mg | 5 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-FED28A | GHK-Cu | CPGHK10026022501 | 99.873% | 106.9%106.87 of 100 mg | 26 Feb 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-50898C | 5-Amino-1MQ | CP5AM26022501 | 99.938% | 148.6%14.86 of 10 mg | 26 Feb 2026 | PASSover 110% of label | Kovera ↗our verifier → |